COVID-19 and the Field of Intellectual and Developmental Disabilities: Where Have We Been? Where Are We? Where Do We Go?

被引：29
作者：
Thompson, James R. [1 ]
Nygren, Margaret A. [2 ]
机构：
[1] Univ Kansas, Lawrence, KS 66045 USA
[2] Amer Assoc Intellectual & Dev Disabil, Washington, DC USA
来源：
INTELLECTUAL AND DEVELOPMENTAL DISABILITIES | 2020年 / 58卷 / 04期
关键词：
COVID; pandemic; community; field; health;
D O I：
10.1352/1934-9556-58.4.257
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
The coronavirus (COVID-19) pandemic has affected, and will continue to affect, every aspect of the intellectual and developmental disabilities (IDD) community. We provide recommendations to (a) support people with IDD and the broader of field of IDD during the course of the pandemic, and (b) place the IDD community in a strong position when the health threats associated with the pandemic abate and post-pandemic social and policy structures are formed.
引用
收藏
页码：257 / 261
页数：5
相关论文
共 50 条
  • [31] Where We've Been and May Go, Standing on the Shoulders of Giants
    Palusci, Vincent J.
    CHILD MALTREATMENT, 2021, 26 (01) : 3 - 8
  • [32] Glaucoma in Black Individuals: How Far Have We Come and Where Do We Go From Here?
    Kitayama, Ken
    Wilson, M. Roy
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 259 : 96 - 101
  • [33] Cancer Survivorship Research in Europe and the United States: Where Have We Been, Where Are We Going, and What Can We Learn From Each Other?
    Rowland, Julia H.
    Kent, Erin E.
    Forsythe, Laura P.
    Loge, Jon Havard
    Hjorth, Lars
    Glaser, Adam
    Mattioli, Vittorio
    Fossa, Sophie D.
    CANCER, 2013, 119 : 2094 - 2108
  • [34] Naturopathy in Australia: Where are we now? Where are we heading?
    Ooi, Soo Liang
    McLean, Lisa
    Pak, Sok Cheon
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2018, 33 : 27 - 35
  • [35] Organizational Health: In Quebec, Where Are We, and Where Are We Going?
    Dagenais-Desmarais, Veronique
    Dufour, Marie-Eve
    St-Hilaire, France
    Hebert, Rachele
    RELATIONS INDUSTRIELLES-INDUSTRIAL RELATIONS, 2013, 68 (04): : 661 - 681
  • [36] International cooperation. Where are we, and where are we heading to?
    Kattan, Eduardo
    Kuroiwa, Aron
    Lopez, Rodrigo
    REVISTA MEDICA DE CHILE, 2017, 145 (06) : 783 - 789
  • [37] Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we go
    Gevaert, Thomas
    Cimadamore, Alessia
    Eckstein, Markus
    Scarpelli, Marina
    Lopez-Beltran, Antonio
    Cheng, Liang
    Montironi, Rodolfo
    FUTURE ONCOLOGY, 2019, 15 (19) : 2199 - 2202
  • [38] Positive Affect and Health: What Do We Know and Where Next Should We Go?
    Pressman, Sarah D.
    Jenkins, Brooke N.
    Moskowitz, Judith T.
    ANNUAL REVIEW OF PSYCHOLOGY, VOL 70, 2019, 70 : 627 - 650
  • [39] Computational methods applied to syphilis: where are we, and where are we going?
    Albuquerque, Gabriela
    Fernandes, Felipe
    Barbalho, Ingridy M. P.
    Barros, Daniele M. S.
    Morais, Philippi S. G.
    Morais, Antonio H. F.
    Santos, Marquiony M.
    Galvao-Lima, Leonardo J.
    Sales-Moioli, Ana Isabela L.
    Santos, Joao Paulo Q.
    Gil, Paulo
    Henriques, Jorge
    Teixeira, Cesar
    Lima, Thaisa Santos
    Coutinho, Karilany D.
    Pinto, Talita K. B.
    Valentim, Ricardo A. M.
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [40] One year update on the COVID-19 pandemic: Where are we now?
    Mishra, Sanjay Kumar
    Tripathi, Timir
    ACTA TROPICA, 2021, 214
12345